\-\ Texto\\:\\ \ \(0\)\
\-\ on\\ exam\\,\\ the\\ child\\ presented\\ with\\ no\\ dysmorphic\\ features\\.\\ \\ his\\ head\\ circumference\\,\\ height\\ and\\ weight\\ were\\ within\\ expected\\ normal\\ limits\\.\\ \\ pupils\\ were\\ reactive\\ bilaterally\\.\\ \\ his\\ speech\\ was\\ well\\ articulated\\ and\\ fluent\\.\\ \\ he\\ exhibited\\ a\\ normal\\ fundoscopic\\ exam\\ as\\ well\\ as\\ full\\ visual\\ fields\\.\\ \\ a\\ right\\ lateral\\ rectus\\ palsy\\ was\\ evident\\.\\ \\ the\\ remainder\\ of\\ his\\ cranial\\ nerve\\ and\\ physical\\ exam\\ showed\\ no\\ evidence\\ of\\ further\\ abnormalities\\.\ \(0\)\
\-\ upon\\ being\\ informed\\ of\\ the\\ mri\\ results\\,\\ the\\ family\\ requested\\ a\\ second\\ opinion\\ to\\ consider\\ surgical\\ resection\\.\\ \\ they\\ brought\\ the\\ child\\ to\\ an\\ outlying\\ tertiary\\ care\\ center\\.\\ \\ there\\ they\\ were\\ set\\ up\\ with\\ radiation\\ therapy\\ and\\ further\\ options\\ such\\ as\\ trials\\ involving\\ combination\\ radiation\\ therapy\\ and\\ adjuvant\\ chemotherapy\\ were\\ presented\\ to\\ the\\ family\\.\\ \\ no\\ further\\ information\\ regarding\\ this\\ child\\'s\\ treatment\\ plan\\ or\\ outcome\\ is\\ known\\ at\\ the\\ time\\ of\\ this\\ publication\\.\ \(0\)\
\-\ image\\ \\#1\\ \\ sagittal\\ t1\\ weighted\\ image\\ without\\ contrast\\ shows\\ evidence\\ of\\ poorly\\ defined\\ diffuse\\ low\\ signal\\ intesity\\ within\\ the\\ pons\\ without\\ evidence\\ of\\ hydrocephalus\\.\ \(0\)\
\-\ image\\ \\#2\\ \\ axial\\ t2\\ weighted\\ image\\ shows\\ evidence\\ of\\ diffuse\\ increased\\ signal\\ within\\ the\\ pons\\ with\\ mild\\ mass\\ effect\\ and\\ effacement\\ of\\ the\\ fourth\\ ventricle\\.\\ \ \(0\)\
\-\ image\\ \\#3\\ \\ sagittal\\ t1\\ weighted\\ image\\ with\\ gadolinum\\ shows\\ evidence\\ of\\ poorly\\ defined\\ diffuse\\ low\\ signal\\ intensity\\ within\\ the\\ pons\\ with\\ a\\ small\\ area\\ of\\ focal\\ enhancement\\ in\\ the\\ posteroinferior\\ region\\ of\\ the\\ pons\\.\\ \\ again\\ no\\ evidence\\ of\\ hydrocephalus\\ is\\ seen\\.\ \(0\)\
\-\ pontine\\ glioma\ \(0\)\
\-\ intraaxial\\ neoplasm\ \(0\)\
\-\ \\â\\€\\¢\\ ependymoma\ \(8\)\
\-\ \\â\\€\\¢\\ gbm\ \(0\)\
\-\ \\â\\€\\¢\\ low\\-grade\\ astrocytoma\ \(0\)\
\-\ \\â\\€\\¢\\ pnet\ \(0\)\
\-\ intraaxial\\ infection\ \(0\)\
\-\ tumefactive\\ demyelination\ \(2\)\
\-\ previously\\ healthy\\ 8\\ year\\ old\\ child\\ with\\ headaches\\ for\\ one\\ year\\ now\\ presents\\ for\\ evaluation\\ of\\ new\\-onset\\ of\\ difficulty\\ moving\\ his\\ right\\ eye\\ laterally\\ accompanied\\ by\\ double\\ vision\\ which\\ has\\ worsened\\ over\\ the\\ last\\ few\\ days\\.\\ \\ the\\ mother\\ states\\ the\\ double\\ vision\\ had\\ been\\ intermittent\\ at\\ first\\ but\\ then\\ had\\ become\\ more\\ prominent\\ and\\ persistent\\.\ \(0\)\
\-\ this\\ family\\ was\\ very\\ interested\\ in\\ a\\ surgical\\ option\\,\\ but\\ several\\ opinions\\ suggested\\ medical\\ therapy\\ would\\ be\\ more\\ important\\ due\\ to\\ the\\ location\\ and\\ size\\ of\\ the\\ tumor\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pons\\:\\ 0\\.24659716662575748\ \(0\)\
\-\ image\\:\\ 0\\.23010537937493833\ \(0\)\
\-\ the\\:\\ 0\\.21537946392492976\ \(0\)\
\-\ evidence\\:\\ 0\\.20422306844723295\ \(0\)\
\-\ child\\:\\ 0\\.1985551245939417\ \(0\)\
\-\ of\\:\\ 0\\.17602821130494214\ \(0\)\
\-\ his\\:\\ 0\\.14547338624875078\ \(0\)\
\-\ family\\:\\ 0\\.14153265037485205\ \(0\)\
\-\ intraaxial\\:\\ 0\\.13955478040540503\ \(0\)\
\-\ weighted\\:\\ 0\\.13419060244635111\ \(0\)\
\-\ were\\:\\ 0\\.12364436566152863\ \(0\)\
\-\ further\\:\\ 0\\.1171719163857215\ \(0\)\
\-\ diffuse\\:\\ 0\\.11281959468319032\ \(0\)\
\-\ within\\:\\ 0\\.11047521682301098\ \(0\)\
\-\ poorly\\:\\ 0\\.10832478635924378\ \(0\)\
\-\ double\\:\\ 0\\.10571659872342704\ \(0\)\
\-\ shows\\:\\ 0\\.10558576250643298\ \(0\)\
\-\ vision\\:\\ 0\\.103872602542017\ \(0\)\
\-\ therapy\\:\\ 0\\.10336424282972392\ \(0\)\
\-\ low\\:\\ 0\\.10322761907842778\ \(0\)\
\-\ signal\\:\\ 0\\.10198021994673184\ \(0\)\
\-\ and\\:\\ 0\\.0991310440158948\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.09790453276435633\ \(0\)\
\-\ articulated\\:\\ 0\\.09589977803408914\ \(0\)\
\-\ opinions\\:\\ 0\\.09589977803408914\ \(0\)\
\-\ sagittal\\:\\ 0\\.09222172063848294\ \(0\)\
\-\ intesity\\:\\ 0\\.09163735763008717\ \(0\)\
\-\ exam\\:\\ 0\\.09056177193977599\ \(0\)\
\-\ posteroinferior\\:\\ 0\\.08861312222496093\ \(0\)\
\-\ gadolinum\\:\\ 0\\.08626734300222835\ \(0\)\
\-\ they\\:\\ 0\\.0856946148139722\ \(0\)\
\-\ defined\\:\\ 0\\.08555983970886684\ \(0\)\
\-\ publication\\:\\ 0\\.08435070182095895\ \(0\)\
\-\ outlying\\:\\ 0\\.08273020479212163\ \(0\)\
\-\ dysmorphic\\:\\ 0\\.08008828141695697\ \(0\)\
\-\ fluent\\:\\ 0\\.08008828141695697\ \(0\)\
\-\ radiation\\:\\ 0\\.0794778096825492\ \(0\)\
\-\ interested\\:\\ 0\\.07898068719310014\ \(0\)\
\-\ no\\:\\ 0\\.0780019295357336\ \(0\)\
\-\ informed\\:\\ 0\\.07797874634299208\ \(0\)\
\-\ fundoscopic\\:\\ 0\\.07544354898299342\ \(0\)\
\-\ opinion\\:\\ 0\\.07544354898299342\ \(0\)\
\-\ t1\\:\\ 0\\.07472597930550416\ \(0\)\
\-\ exhibited\\:\\ 0\\.07471826678909815\ \(0\)\
\-\ trials\\:\\ 0\\.07471826678909815\ \(0\)\
\-\ tertiary\\:\\ 0\\.0740398106067045\ \(0\)\
\-\ as\\:\\ 0\\.07227223224303596\ \(0\)\
\-\ with\\:\\ 0\\.07045335524770065\ \(0\)\
\-\ presented\\:\\ 0\\.06993834371919552\ \(0\)\
\-\ adjuvant\\:\\ 0\\.06977739020270252\ \(0\)\
\-\ demyelination\\:\\ 0\\.06977739020270252\ \(0\)\
\-\ set\\:\\ 0\\.06893594746556758\ \(0\)\
\-\ pontine\\:\\ 0\\.06853920520382678\ \(0\)\
\-\ circumference\\:\\ 0\\.06815689317386521\ \(0\)\
\-\ tumefactive\\:\\ 0\\.06815689317386521\ \(0\)\
\-\ more\\:\\ 0\\.06585624372605839\ \(0\)\
\-\ accompanied\\:\\ 0\\.06551496979870056\ \(0\)\
\-\ plan\\:\\ 0\\.06522694021417465\ \(0\)\
\-\ moving\\:\\ 0\\.06522694021417465\ \(0\)\
\-\ pnet\\:\\ 0\\.06440737557484372\ \(0\)\
\-\ outcome\\:\\ 0\\.06389447276986322\ \(0\)\
\-\ gbm\\:\\ 0\\.06340543472473566\ \(0\)\
\-\ without\\:\\ 0\\.06326033952011212\ \(0\)\
\-\ regarding\\:\\ 0\\.06293813902903493\ \(0\)\
\-\ requested\\:\\ 0\\.06271205671982169\ \(0\)\
\-\ was\\:\\ 0\\.06269694629558988\ \(0\)\
\-\ rectus\\:\\ 0\\.062061596352111136\ \(0\)\
\-\ speech\\:\\ 0\\.06185342277329467\ \(0\)\
\-\ this\\:\\ 0\\.06181689472237205\ \(0\)\
\-\ laterally\\:\\ 0\\.0606841719374979\ \(0\)\
\-\ option\\:\\ 0\\.06050134259530836\ \(0\)\
\-\ palsy\\:\\ 0\\.05997119217005116\ \(0\)\
\-\ to\\:\\ 0\\.059966210036379405\ \(0\)\
\-\ worsened\\:\\ 0\\.05980025470944706\ \(0\)\
\-\ had\\:\\ 0\\.05975521077742733\ \(0\)\
\-\ pupils\\:\\ 0\\.05946649898844807\ \(0\)\
\-\ effacement\\:\\ 0\\.05946649898844807\ \(0\)\
\-\ but\\:\\ 0\\.059307235126040865\ \(0\)\
\-\ information\\:\\ 0\\.059303512433706795\ \(0\)\
\-\ brought\\:\\ 0\\.05914301432073367\ \(0\)\
\-\ fields\\:\\ 0\\.058984929804878364\ \(0\)\
\-\ consider\\:\\ 0\\.058984929804878364\ \(0\)\
\-\ surgical\\:\\ 0\\.058291526361503726\ \(0\)\
\-\ well\\:\\ 0\\.05807232530315745\ \(0\)\
\-\ height\\:\\ 0\\.057522517291896356\ \(0\)\
\-\ suggested\\:\\ 0\\.05611877891560744\ \(0\)\
\-\ combination\\:\\ 0\\.05565148321990672\ \(0\)\
\-\ center\\:\\ 0\\.054262037738002436\ \(0\)\
\-\ expected\\:\\ 0\\.05406368426471137\ \(0\)\
\-\ options\\:\\ 0\\.05406368426471137\ \(0\)\
\-\ fourth\\:\\ 0\\.053772999692874864\ \(0\)\
\-\ again\\:\\ 0\\.0534901371874407\ \(0\)\
\-\ become\\:\\ 0\\.053214686786180146\ \(0\)\
\-\ remainder\\:\\ 0\\.052771058842766796\ \(0\)\
\-\ states\\:\\ 0\\.05268453636092295\ \(0\)\
\-\ evident\\:\\ 0\\.05154253155904022\ \(0\)\
\-\ reactive\\:\\ 0\\.051465517132534604\ \(0\)\
\-\ mother\\:\\ 0\\.051237802332876205\ \(0\)\
\-\ visual\\:\\ 0\\.0511629805066915\ \(0\)\
\-\ glioma\\:\\ 0\\.050941658180444126\ \(0\)\
\-\ healthy\\:\\ 0\\.05086890756344757\ \(0\)\
\-\ few\\:\\ 0\\.05086890756344757\ \(0\)\
\-\ important\\:\\ 0\\.050796656954641584\ \(0\)\
\-\ ependymoma\\:\\ 0\\.050653628595918224\ \(0\)\
\-\ difficulty\\:\\ 0\\.05044266990059309\ \(0\)\
\-\ cranial\\:\\ 0\\.04901285687959963\ \(0\)\
\-\ intermittent\\:\\ 0\\.04901285687959963\ \(0\)\
\-\ normal\\:\\ 0\\.04896798768730147\ \(0\)\
\-\ last\\:\\ 0\\.048772562481426994\ \(0\)\
\-\ features\\:\\ 0\\.04825117849631687\ \(0\)\
\-\ previously\\:\\ 0\\.04813874510156527\ \(0\)\
\-\ eye\\:\\ 0\\.047972318055155075\ \(0\)\
\-\ limits\\:\\ 0\\.0473836826548916\ \(0\)\
\-\ prominent\\:\\ 0\\.04722870556507149\ \(0\)\
\-\ upon\\:\\ 0\\.04717755012495068\ \(0\)\
\-\ full\\:\\ 0\\.046875737370493685\ \(0\)\
\-\ results\\:\\ 0\\.046728019405510635\ \(0\)\
\-\ persistent\\:\\ 0\\.04620348137831249\ \(0\)\
\-\ at\\:\\ 0\\.04530034930008077\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.045269417582106536\ \(0\)\
\-\ second\\:\\ 0\\.044893187370191656\ \(0\)\
\-\ headaches\\:\\ 0\\.04473020081545038\ \(0\)\
\-\ ventricle\\:\\ 0\\.04414056466101407\ \(0\)\
\-\ abnormalities\\:\\ 0\\.043438243718767505\ \(0\)\
\-\ very\\:\\ 0\\.04301769075103626\ \(0\)\
\-\ care\\:\\ 0\\.0428473074069861\ \(0\)\
\-\ nerve\\:\\ 0\\.04277991985443342\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.042580310904211306\ \(0\)\
\-\ intensity\\:\\ 0\\.042580310904211306\ \(0\)\
\-\ then\\:\\ 0\\.0424493132938356\ \(0\)\
\-\ would\\:\\ 0\\.0424493132938356\ \(0\)\
\-\ effect\\:\\ 0\\.042065838963889365\ \(0\)\
\-\ involving\\:\\ 0\\.04200326483746484\ \(0\)\
\-\ weight\\:\\ 0\\.041817746689930185\ \(0\)\
\-\ being\\:\\ 0\\.041787142819115\ \(0\)\
\-\ location\\:\\ 0\\.041756627784043945\ \(0\)\
\-\ now\\:\\ 0\\.0411642219227808\ \(0\)\
\-\ neoplasm\\:\\ 0\\.040936301402587354\ \(0\)\
\-\ size\\:\\ 0\\.04060342645090735\ \(0\)\
\-\ first\\:\\ 0\\.0404677804114484\ \(0\)\
\-\ bilaterally\\:\\ 0\\.039993455345910034\ \(0\)\
\-\ showed\\:\\ 0\\.03994204975594328\ \(0\)\
\-\ right\\:\\ 0\\.039762871983303104\ \(0\)\
\-\ several\\:\\ 0\\.039344025658351336\ \(0\)\
\-\ area\\:\\ 0\\.03884728338261108\ \(0\)\
\-\ known\\:\\ 0\\.03882420451011326\ \(0\)\
\-\ such\\:\\ 0\\.03857362570335285\ \(0\)\
\-\ resection\\:\\ 0\\.038439422746274356\ \(0\)\
\-\ medical\\:\\ 0\\.03811122474266652\ \(0\)\
\-\ days\\:\\ 0\\.03796150307574269\ \(0\)\
\-\ year\\:\\ 0\\.036961101009692215\ \(0\)\
\-\ evaluation\\:\\ 0\\.0365710463464517\ \(0\)\
\-\ for\\:\\ 0\\.03635088169736334\ \(0\)\
\-\ infection\\:\\ 0\\.03622334533638517\ \(0\)\
\-\ focal\\:\\ 0\\.03586935828233666\ \(0\)\
\-\ region\\:\\ 0\\.03586935828233666\ \(0\)\
\-\ head\\:\\ 0\\.03576544551993394\ \(0\)\
\-\ time\\:\\ 0\\.03554376416900456\ \(0\)\
\-\ he\\:\\ 0\\.035510070479261344\ \(0\)\
\-\ been\\:\\ 0\\.03493726767061646\ \(0\)\
\-\ axial\\:\\ 0\\.03463891154085891\ \(0\)\
\-\ enhancement\\:\\ 0\\.034515777808610676\ \(0\)\
\-\ t2\\:\\ 0\\.034500487009986786\ \(0\)\
\-\ due\\:\\ 0\\.034469971974915734\ \(0\)\
\-\ one\\:\\ 0\\.034333739975076445\ \(0\)\
\-\ mild\\:\\ 0\\.03399340664891061\ \(0\)\
\-\ over\\:\\ 0\\.033344111157061464\ \(0\)\
\-\ is\\:\\ 0\\.032844566125044335\ \(0\)\
\-\ physical\\:\\ 0\\.032515311142076314\ \(0\)\
\-\ increased\\:\\ 0\\.032427129731782356\ \(0\)\
\-\ tumor\\:\\ 0\\.031366053507818514\ \(0\)\
\-\ small\\:\\ 0\\.03093283376480901\ \(0\)\
\-\ mri\\:\\ 0\\.03078157328178048\ \(0\)\
\-\ in\\:\\ 0\\.029835528237387315\ \(0\)\
\-\ lateral\\:\\ 0\\.029760146935453136\ \(0\)\
\-\ up\\:\\ 0\\.02966325756571384\ \(0\)\
\-\ contrast\\:\\ 0\\.029136586032896677\ \(0\)\
\-\ presents\\:\\ 0\\.028847069016857792\ \(0\)\
\-\ treatment\\:\\ 0\\.028565312192649583\ \(0\)\
\-\ seen\\:\\ 0\\.028231827973663828\ \(0\)\
\-\ has\\:\\ 0\\.02739103269270502\ \(0\)\
\-\ which\\:\\ 0\\.02726744658513194\ \(0\)\
\-\ by\\:\\ 0\\.02546533075172879\ \(0\)\
\-\ be\\:\\ 0\\.024326085228172763\ \(0\)\
\-\ there\\:\\ 0\\.023860556347333604\ \(0\)\
\-\ an\\:\\ 0\\.02293105760133999\ \(0\)\
\-\ mass\\:\\ 0\\.022905671396777783\ \(0\)\
\-\ or\\:\\ 0\\.020861340602253572\ \(0\)\
\-\ on\\:\\ 0\\.01811096703603193\ \(0\)\
\-\ old\\:\\ 0\\.017747725685966144\ \(0\)\
